Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer

NCT04072731 is registered in ClinicalTrials.gov with People's Hospital of Zhengzhou University as lead sponsor.

NCT NCT04072731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04072731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer
Lead sponsor
People's Hospital of Zhengzhou University
Phase
Observational
Overall status
Completed
Start date
January 16, 2016
Completion date
January 1, 2018
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer